Clinical impact of rebiopsy among patients with epidermal growth factor receptor‐mutant lung adenocarcinoma in a real‐world clinical setting

Clinical impact of rebiopsy among patients with epidermal growth factor receptor‐mutant lung adenocarcinoma in a real‐world clinical setting

Abstract Background In this study, we investigated the risk factors of acquired T790M mutation among patients with lung adenocarcinoma with epidermal growth factor receptor (EGFR) tyrosine mutation who were treated with EGFR‐tyrosine kinase inhibitors (TKIs). The aim was to identify the clinical imp...

Full description

Bibliographic Details
Main Authors: Yunha Nam, Ho Cheol Kim, Young‐Chul Kim, Seung Hun Jang, Kye Young Lee, Shin Yup Lee, Sang Hoon Lee, Sung Yong Lee, Seong Hoon Yoon, Jeong‐Seon Ryu, Tae Won Jang, Yoon Soo Chang, Seung Joon Kim, Chan Kwon Park, Jeong Eun Lee, Chi Young Jung, Chang‐Min Choi
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:Thoracic Cancer
Subjects:
lung cancer
EGFR‐TKI
acquired resistance
T790M
rebiopsy
Online Access:https://doi.org/10.1111/1759-7714.13857

Internet

https://doi.org/10.1111/1759-7714.13857

Similar Items